Synergism between the components of the bipartite major immediate-early transcriptional enhancer of murine cytomegalovirus does not accelerate virus replication in cell culture and host tissues

References

1. Adachi N., Lieber M. R. 2002; Bidirectional gene organization: a common architectural feature of the human genome. Cell 109:807–809 [CrossRef]
   [Google Scholar]
2. Angulo A., Messerle M., Koszinowski U. H., Ghazal P. 1998; Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer. J Virol 72:8502–8509
   [Google Scholar]
3. Angulo A., Ghazal P., Messerle M. 2000; The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth. J Virol 74:11129–11136 [CrossRef]
   [Google Scholar]
4. Bailey T. L., Gribskov M. 1998; Combining evidence using p-values: application to sequence homology searches. Bioinformatics 14:48–54 [CrossRef]
   [Google Scholar]
5. Bain M., Reeves M., Sinclair J. 2006; Regulation of human cytomegalovirus gene expression by chromatin remodeling. In Cytomegaloviruses: Molecular Biology and Immunology pp 167–183Edited by Reddehase M. J. Wymondham, UK: Caister Academic Press;
   [Google Scholar]
6. Baskar J. F., Smith P. P., Nilaver G., Jupp R. A., Hoffmann S., Peffer N. J., Tenney D. J., Colberg-Poley A. M., Ghazal P., Nelson J. A. 1996; The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 70:3207–3214
   [Google Scholar]
7. Blackwood E. M., Kadonaga J. T. 1998; Going the distance: a current view of enhancer action. Science 281:60–63 [CrossRef]
   [Google Scholar]
8. Boshart M., Weber F., Jahn G., Dorsch-Häsler K., Fleckenstein B., Schaffner W. 1985; A very strong enhancer is located upstream of an immediate-early gene of human cytomegalovirus. Cell 41:521–530 [CrossRef]
   [Google Scholar]
9. Bühler B., Keil G. M., Weiland F., Koszinowski U. H. 1990; Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J Virol 64:1907–1919
   [Google Scholar]
10. Busche A., Angulo A., Kay-Jackson P., Ghazal P., Messerle M. 2008; Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol 197:233–240 [CrossRef]
    [Google Scholar]
11. Busche A., Marquardt A., Bleich A., Ghazal P., Angulo A., Messerle M. 2009; The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs. J Virol 83:4030–4038 [CrossRef]
    [Google Scholar]
12. Campbell A. E., Cavanaugh V. J., Slater J. S. 2008; The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 197:205–213 [CrossRef]
    [Google Scholar]
13. Cardin R. D., Abenes G. B., Stoddard C. A., Mocarski E. S. 1995; Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236–241 [CrossRef]
    [Google Scholar]
14. Chatellard P., Pankiewicz R., Meier E., Durrer L., Sauvage C., Imhof M. O. 2007; The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells. Biotechnol Bioeng 96:106–117 [CrossRef]
    [Google Scholar]
15. Ciocco-Schmitt G. M., Karabekian Z., Godfrey E. W., Stenberg R. M., Campbell A. E., Kerry J. A. 2002; Identification and characterization of novel murine cytomegalovirus M112–113 (e1) gene products. Virology 294:199–208 [CrossRef]
    [Google Scholar]
16. Dorsch-Häsler K., Keil G. M., Weber F., Jasin M., Schaffner W., Koszinowski U. H. 1985; A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A 82:8325–8329 [CrossRef]
    [Google Scholar]
17. Fiering S., Whitelaw E., Martin D. I. K. 2000; To be or not to be active: the stochastic nature of enhancer action. Bioessays 22:381–387 [CrossRef]
    [Google Scholar]
18. Ghazal P., Messerle M., Osborn K., Angulo A. 2003; An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis. J Virol 77:3217–3228 [CrossRef]
    [Google Scholar]
19. Ghazal P., Visser A. E., Gustems M., Garcia R., Borst E. M., Sullivan K., Messerle M., Angulo A. 2005; Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture. J Virol 79:7182–7194 [CrossRef]
    [Google Scholar]
20. Gribaudo G., Riera L., Lembo D., De Andrea M., Gariglio M., Rudge T. L., Johnson L. F., Landolfo S. 2000; Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol 74:4979–4987 [CrossRef]
    [Google Scholar]
21. Grzimek N. K. A., Podlech J., Steffens H.-P., Holtappels R., Schmalz S., Reddehase M. J. 1999; In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter–enhancer of human cytomegalovirus. J Virol 73:5043–5055
    [Google Scholar]
22. Gustems M., Busche A., Messerle M., Ghazal P., Angulo A. 2008; In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation. J Virol 82:10302–10307 [CrossRef]
    [Google Scholar]
23. Jonjić S., Mutter W., Weiland F., Reddehase M. J., Koszinowski U. H. 1989; Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4⁺ T-lymphocytes. J Exp Med 169:1199–1212 [CrossRef]
    [Google Scholar]
24. Keil G. M., Fibi M. R., Koszinowski U. H. 1985; Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. J Virol 54:422–428
    [Google Scholar]
25. Keil G. M., Ebeling-Keil A., Koszinowski U. H. 1987a; Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol 61:526–533
    [Google Scholar]
26. Keil G. M., Ebeling-Keil A., Koszinowski U. H. 1987b; Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J Virol 61:1901–1908
    [Google Scholar]
27. Kurz S., Steffens H.-P., Mayer A., Harris J. R., Reddehase M. J. 1997; Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 71:2980–2987
    [Google Scholar]
28. Lee E.-C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D. A., Court D. L., Jenkins N. A., Copeland N. G. 2001; A highly efficient Escherichia coli -based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56–65 [CrossRef]
    [Google Scholar]
29. Lembo D., Gribaudo G., Hofer A., Riera L., Cornaglia M., Mondo A., Angeretti A., Gariglio M., Thelander L., Landolfo S. 2000; Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. J Virol 74:11557–11565 [CrossRef]
    [Google Scholar]
30. Li Z. T., Jayasankar S., Gray D. J. 2004; Bi-directional duplex promoters with duplicated enhancers significantly increase transgene expression in grape and tobacco. Transgenic Res 13:143–154 [CrossRef]
    [Google Scholar]
31. Liu X. F., Yan S., Abecassis M., Hummel M. 2008; Establishment of murine cytomegalovirus latency in vivo is associated with changes in histone modifications and recruitment of transcriptional repressors to the major immediate-early promoter. J Virol 82:10922–10931 [CrossRef]
    [Google Scholar]
32. Manning W. C., Mocarski E. S. 1988; Insertional mutagenesis of the murine cytomegalovirus genome: one prominent α gene ( ie2 ) is dispensable for growth. Virology 167:477–484
    [Google Scholar]
33. Maul G. G. 2008; Initiation of cytomegalovirus infection at ND10. Curr Top Microbiol Immunol 325:117–132
    [Google Scholar]
34. Maul G. G., Negorev D. 2008; Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle. Med Microbiol Immunol 197:241–249 [CrossRef]
    [Google Scholar]
35. Meier J. L., Stinski M. F. 2006; Major immediate-early enhancer and its gene products. In Cytomegaloviruses: Molecular Biology and Immunology pp 151–166Edited by Reddehase M. J. Wymondham, UK: Caister Academic Press;
    [Google Scholar]
36. Messerle M., Keil G. M., Koszinowski U. H. 1991; Structure and expression of murine cytomegalovirus immediate-early gene 2. J Virol 65:1638–1643
    [Google Scholar]
37. Messerle M., Bühler B., Keil G. M., Koszinowski U. H. 1992; Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol 66:27–36
    [Google Scholar]
38. Murphy J. C., Fischle W., Verdin E., Sinclair J. H. 2002; Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J 21:1112–1120 [CrossRef]
    [Google Scholar]
39. Podlech J., Holtappels R., Wirtz N., Steffens H.-P., Reddehase M. J. 1998; Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J Gen Virol 79:2099–2104
    [Google Scholar]
40. Podlech J., Holtappels R., Grzimek N. K. A., Reddehase M. J. 2002; Animal models: murine cytomegalovirus. In Immunology of Infection , 2nd edn. Methods in Microbiology vol. 32 pp 493–525Edited by Kaufmann S. H. E., Kabelitz. London: Academic Press;
    [Google Scholar]
41. Rawlinson W. D., Farrell H. E., Barrell B. G. 1996; Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70:8833–8849
    [Google Scholar]
42. Reddehase M. J., Simon C. O., Seckert C. K., Lemmermann N., Grzimek N. K. A. 2008; Murine model of cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325:315–332
    [Google Scholar]
43. Sacher T., Podlech J., Mohr C. A., Jordan S., Ruzsics Z., Reddehase M. J., Koszinowski U. H. 2008; The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3:263–272 [CrossRef]
    [Google Scholar]
44. Sandelin A., Alkema W., Engström P., Wasserman W. W., Lenhard B. 2004; jaspar: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acid Res 32:D91–D94 [CrossRef]
    [Google Scholar]
45. Simon C. O., Seckert C. K., Dreis D., Reddehase M. J., Grzimek N. K. 2005; Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 79:326–340 [CrossRef]
    [Google Scholar]
46. Simon C. O., Holtappels R., Tervo H.-M., Böhm V., Däubner T., Oehrlein-Karpi S. A., Kühnapfel B., Renzaho A., Strand D. other authors 2006; CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80:10436–10456 [CrossRef]
    [Google Scholar]
47. Simon C. O., Kühnapfel B., Reddehase M. J., Grzimek N. K. A. 2007; Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription. J Virol 81:7805–7810 [CrossRef]
    [Google Scholar]
48. Sinzger C., Digel M., Jahn G. 2008; Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63–83
    [Google Scholar]
49. Stinski M. F., Isomura H. 2008; Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol 197:223–231 [CrossRef]
    [Google Scholar]
50. Trinklein N. D., Aldred S. F., Hartman S. J., Schroeder D. I., Otillar R. P., Myers R. M. 2004; An abundance of bidirectional promoters in the human genome. Genome Res 14:62–66
    [Google Scholar]
51. Wagner M., Jonjić S., Koszinowski U. H., Messerle M. 1999; Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 73:7056–7060
    [Google Scholar]
52. Warming S., Costantino N., Court D. L., Jenkins N. A., Copeland N. G. 2005; Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33:e36 [CrossRef]
    [Google Scholar]
53. Wilhelmi V., Simon C. O., Podlech J., Böhm V., Däubner T., Emde S., Strand D., Renzaho A., Lemmermann N. A. W., & other authors D. 2008; Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues. J Virol 82:9900–9916 [CrossRef]
    [Google Scholar]